Trial of Chidamide in Combination With Exemestane in Patients With Advanced Breast Cancer

NCT02482753 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

365

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Chidamide
DRUG: exemestane
DRUG: placebo

Sponsor

Chipscreen Biosciences, Ltd.